Envoy Medical (COCH) Operating Expenses (2021 - 2026)

Envoy Medical has disclosed Operating Expenses across 6 years of filings, most recently posting -$1.6 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at -$1.6 million, down 160.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.8 million (up 13.16% YoY), and the FY2025 annual result was $22.5 million, up 15.55% from the prior year.
• Operating Expenses came in at -$1.6 million for Q1 2026 at Envoy Medical, down from $6.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $6.8 million in Q4 2023 to a low of -$1.6 million in Q1 2026.
• The 5-year median for Operating Expenses is $4.5 million (2023), against an average of $3.6 million.
• Across the five-year window, Operating Expenses surged 404.02% in 2023 and sank 160.49% in 2026, its largest moves.
• Envoy Medical's Operating Expenses stood at $2.9 million in 2022, then soared by 133.01% to $6.8 million in 2023, then slumped by 32.66% to $4.6 million in 2024, then jumped by 40.71% to $6.5 million in 2025, then tumbled by 124.8% to -$1.6 million in 2026.
• The last three Operating Expenses figures came in at -$1.6 million (Q1 2026), $6.5 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.